Schroders Capital
Investor profile
Venture capital
Also recorded as: Schroders
Deals
21
distinct rounds
Companies
18
backed
Active span
2014–2026
13 yrs
Total round €
€2.4B
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- 3B Future Health Fund3
- Balderton Capital3
- Sofinnova Partners3
- Avidity Partners2
- Invus2
- Lightspeed Venture Partners2
- M Ventures2
- Novartis Venture Fund2
- Omega Funds2
- Piper Heartland Healthcare Capital2
- Pureos Bioventures2
- Redalpine2
- VI Partners2
- +ND Capital1
- 4BIO Capital1
- 4see Ventures1
- 8090 Partners1
- Adjuvant Capital1
- adMare BioInnovations1
- AlbionVC1
- Alexandria Venture Investments1
- Allianz1
- Andera Partners1
- Apollo Health Ventures1
- Armada Investment Group1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Wayve | UK | 1 | €1.0B |
| Cera | UK | 2 | €307M |
| Artios | UK | 2 | €229M |
| Azafaros | Netherlands | 1 | €132M |
| Proeduca | Spain | 1 | €90M |
| Multiverse | UK | 1 | €80M |
| iOnctura | Switzerland | 1 | €80M |
| Fastned | Netherlands | 1 | €75M |
| Luminance | UK | 1 | €72M |
| tem | UK | 1 | €63M |
| Nutmeg | UK | 2 | €62M |
| haya therapeutics | Switzerland | 1 | €57M |
| Domain Therapeutics | France | 1 | €40M |
| Epsilogen | UK | 1 | €37M |
| Memo Therapeutics | Switzerland | 1 | €26M |
| Araris Biotech | Switzerland | 1 | €24M |
| Be.EV | UK | 1 | €24M |
| Healthy Workers | Netherlands | 1 | €3.6M |